Clinical Trials
117 trialsINSPIRE
Singlera Genomics Inc.
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Air Force Military Medical University, China
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Qurgen Inc.
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
POSITive
European Institute of Oncology
PITHAC
Centre Hospitalier Universitaire Vaudois
VUBAR
Universitair Ziekenhuis Brussel
Family History Study on Cancer Risk
Kaiser Permanente
ELEGANT
Centre Leon Berard
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
University Hospital, Ghent
Phys-Can
Uppsala University
UPLIFT
Massachusetts General Hospital
Minnelide 101
Minneamrita Therapeutics LLC
CAT_PB
Lebanese University
ROME
Fondazione per la Medicina Personalizzata
IMX-110 in Patients With Advanced Solid Tumors
Immix Biopharma, Inc.
Adapting the Tumor Board Model for Mental Illness and Cancer
Massachusetts General Hospital
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
The ONE-MIND Study: Evaluating the Efficacy of Online Mindfulness-Based Cancer Recovery During Chemotherapy Treatment
University of Calgary
DEFACTO2
Université Sorbonne Paris Nord
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Chongqing Precision Biotech Co., Ltd
CADENCE
MiRXES Pte Ltd
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
RIVAGE
Assistance Publique - Hôpitaux de Paris
WEE1
Impact Therapeutics, Inc.
Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients
China Medical University Hospital
GEN602
Genzada Pharmaceuticals USA, Inc.
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
Karolinska University Hospital
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
RESTORE
Blue Note Therapeutics
Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
Moscow Clinical Scientific Center
GenoVA
Boston VA Research Institute, Inc.
Coala-T-CBD
Main Line Health
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Silverback Therapeutics
PASSION
Assistance Publique - Hôpitaux de Paris
SPACE2
Weprom
X7-7
University of Kansas Medical Center
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Def_Special
Moscow Clinical Scientific Center
HSP70CTC
Charite University, Berlin, Germany
Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy
University of Florence
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
Peking University Cancer Hospital & Institute